Advertisement

Topics

Biolink Group AS Company Profile

11:58 EDT 25th June 2018 | BioPortfolio

Biolink Group is based on research and development of novel pharmaceutical molecules such as anthocyanins and other polyphenols. The Company has four operational programs within its portfolio

Location

Hanaveien 4-6
Sandnes
4327
Norway

Contact

Phone: 47 5167 5650
Fax: 47 5162 5182
Email: mail@biolink.no


News Articles [397 Associated News Articles listed on BioPortfolio]

Unlimited Group appoints group managing director

Michael Richards joins the group from VCCP

TMX Group Limited Declares Dividend of $0.50 per Common Share

For the results of the quarter ended December 31, 2017for TMX Group, please click on the following link: http://www.tmx.com/investor-relations/ About TMX Group (TSX:X) TMX Read more...

North 6th Agency Announces N6-Accolades For March 2018

The N6A Cybersecurity & Digital Identity Group took home the "N6A Golden Group" trophy as the highest-performing group for the month. At the end of Read more...

Predictive Technology Group to Acquire FlagshipHealth Group

Predictive Technology Group, Inc., a provider of data analytics for disease identification and subsequent therapeutic intervention through unique biotechnology treatments has finalized an arrangement ...

New haematology patient group launched

The launch of a new patient engagement group for those with blood conditions has brought together patients, clinicians and researchers to discuss how to get patient involved in research. A screening o...

Group 1 Automotive Appoints UK Operating Leader

HOUSTON, Feb. 28, 2018/PRNewswire/ --  Group 1 Automotive, Inc. (NYSE: GPI), ("Group 1" or the "Company"), an international, Fortune 500 automotive retailer, Read more...

Group 1 Automotive Acquires Two Additional Dealerships in El Paso, Texas

HOUSTON, Jan. 29, 2018/PRNewswire/ --  Group 1 Automotive, Inc. (NYSE: GPI), ("Group 1" or the "Company"), an international, Fortune 500 automotive Read more...

Group medical visits fail to improve outcomes in patients with diabetes

Group medical visits — the combination of group self-management education and one-on-one consultations with clinicians — did not improve several medical outcomes in patients with diabetes, accordi...

PubMed Articles [1797 Associated PubMed Articles listed on BioPortfolio]

Group Influences on Engaging Self-Control: Children Delay Gratification and Value It More When Their In-Group Delays and Their Out-Group Doesn't.

Self-control emerges in a rich sociocultural context. Do group norms around self-control influence the degree to which children use it? We tested this possibility by assigning 3- to 5-year-old childre...

An Examination of Group Size and Valence in Delay Discounting of Shared Outcomes.

Previous research has examined delay discounting in a group context, where the outcomes are shared with others. These studies indicate shallow delay discounting in a group context compared to an indiv...

Ameliorating effects of tempol on methotrexate-induced liver injury in rats.

Methotrexate (MTX) is used in the treatment of certain types of cancers and chronic inflammatory illnesses, although the clinical use of MTX is limited due to its adverse effects, the most common of w...

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

Medulloblastoma, the most common malignant pediatric brain tumor, is a heterogeneous disease, with the existence of at least four molecular types: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Gro...

Nephroprotective Effect of Zingerone against CCl-Induced Renal Toxicity in Swiss Albino Mice: Molecular Mechanism.

The protective effects of Zingerone against CCl induced nephrotoxicity in Swiss albino mice via modulation of metabolizing enzyme, oxidative stress, inflammatory cytokines, and apoptosis. The biochemi...

Clinical Trials [3703 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

the Influence of Sleep Improvement Through Different Methods on Patients in ICU

In the research, we enroll 120 postoperative patients in the ICU and they will be assigned to four group: the eye patch group, the Dexmedetomidine(DEX) group, the eye patch+DEX group and t...

Companies [1618 Associated Companies listed on BioPortfolio]

Biolink Group AS

Biolink Group is based on research and development of novel pharmaceutical molecules such as anthocyanins and other polyphenols. The Company has four operational programs within its portfolio

BioLink

Biolink® Corporation is a privately held medical device company focused on developing solutions for vascular access. The Company’s lead product, Neutrolin™, is an innovative liquid ant...

InVasc Therapeutics, Inc. and BioLink Life Sciences, Inc.

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

More Information about "Biolink Group AS" on BioPortfolio

We have published hundreds of Biolink Group AS news stories on BioPortfolio along with dozens of Biolink Group AS Clinical Trials and PubMed Articles about Biolink Group AS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biolink Group AS Companies in our database. You can also find out about relevant Biolink Group AS Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record